269 related articles for article (PubMed ID: 21628855)
41. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
[TBL] [Abstract][Full Text] [Related]
42. Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.
Johnson SM; Umakanthan JM; Yuan J; Fedoriw Y; Bociek RG; Kaiser-Rogers K; Sanmann JN; Montgomery ND
Hum Pathol; 2018 Oct; 80():192-200. PubMed ID: 29902576
[TBL] [Abstract][Full Text] [Related]
43. Detection of t(8;14) c-myc/IgH gene rearrangement by long-distance polymerase chain reaction in patients with diffuse large B-cell lymphoma.
Kiaei A; Onsori H; Alijani A; Andalib S; Ghorbian S; Sakhinia E
Hematol Oncol Stem Cell Ther; 2016 Dec; 9(4):141-146. PubMed ID: 27352258
[TBL] [Abstract][Full Text] [Related]
44. [Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
Hashimoto A; Fujimi A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Matsumoto T; Shibata T; Hamaguchi K; Kamihara Y; Iwasaki S; Kato J
Rinsho Ketsueki; 2015 Jul; 56(7):905-10. PubMed ID: 26256929
[TBL] [Abstract][Full Text] [Related]
45. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
[TBL] [Abstract][Full Text] [Related]
46. Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma.
Oliveira CC; Maciel-Guerra H; Kucko L; Hirama EJ; Brilhante AD; Quevedo FC; da Cunha IW; Soares FA; Niero-Melo L; Dos Reis PP; Domingues MA
Diagn Pathol; 2017 Jan; 12(1):3. PubMed ID: 28061782
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological prognostic factors of 24 patients with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Miyamoto K; Kobayashi Y; Maeshima AM; Taniguchi H; Nomoto J; Kitahara H; Fukuhara S; Munakata W; Maruyama D; Tobinai K
Int J Hematol; 2016 Jun; 103(6):693-702. PubMed ID: 27095041
[TBL] [Abstract][Full Text] [Related]
48. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
49. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
[TBL] [Abstract][Full Text] [Related]
50. The t(8;14)(q24.1;q32) and its variant translocations: A study of 34 cases.
Angi M; Kamath V; Yuvarani S; Meena J; Sitaram U; Manipadam MT; Nair S; Ganapule A; Fouzia NA; Abraham A; Viswabandya A; Poonkuzhali B; George B; Mathews V; Srivastava A; Srivastava VM
Hematol Oncol Stem Cell Ther; 2017 Sep; 10(3):126-134. PubMed ID: 28390216
[TBL] [Abstract][Full Text] [Related]
51. [Clinical features in DLBCL and translocation BCL2/c-MYC "double hit" lymphoma].
Škunca Ž; Domimis M; Plninc-Peraica A; Jakšić B
Acta Med Croatica; 2014 Jun; 68(3):299-305. PubMed ID: 26016222
[TBL] [Abstract][Full Text] [Related]
52. A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma.
Impera L; Albano F; Lo Cunsolo C; Funes S; Iuzzolino P; Laveder F; Panagopoulos I; Rocchi M; Storlazzi CT
Oncogene; 2008 Oct; 27(47):6187-90. PubMed ID: 18622426
[TBL] [Abstract][Full Text] [Related]
53. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
54. MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.
Petrich AM; Nabhan C; Smith SM
Cancer; 2014 Dec; 120(24):3884-95. PubMed ID: 25060588
[TBL] [Abstract][Full Text] [Related]
55. MYC expression and translocation analyses in low-grade and transformed follicular lymphoma.
Aukema SM; van Pel R; Nagel I; Bens S; Siebert R; Rosati S; van den Berg E; Bosga-Bouwer AG; Kibbelaar RE; Hoogendoorn M; van Imhoff GW; Kluin-Nelemans HC; Kluin PM; Nijland M
Histopathology; 2017 Dec; 71(6):960-971. PubMed ID: 28730642
[TBL] [Abstract][Full Text] [Related]
56. Double-hit lymphoma at second relapse of Burkitt-like lymphoma: a case report.
Tanaka H; Hashimoto S; Abe D; Sakai S; Takagi T
J Clin Exp Hematop; 2011; 51(1):43-7. PubMed ID: 21628860
[TBL] [Abstract][Full Text] [Related]
57. TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations.
Gebauer N; Bernard V; Gebauer W; Thorns C; Feller AC; Merz H
Leuk Lymphoma; 2015 Jan; 56(1):179-85. PubMed ID: 24679006
[TBL] [Abstract][Full Text] [Related]
58. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
Merchant S; Schlette E; Sanger W; Lai R; Medeiros LJ
Arch Pathol Lab Med; 2003 Mar; 127(3):305-9. PubMed ID: 12653573
[TBL] [Abstract][Full Text] [Related]
59. Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience.
Pedersen MØ; Gang AO; Poulsen TS; Knudsen H; Lauritzen AF; Nielsen SL; Gang UO; Nørgaard P
Eur J Haematol; 2012 Jul; 89(1):63-71. PubMed ID: 22510149
[TBL] [Abstract][Full Text] [Related]
60. Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.
Mossafa H; Damotte D; Jenabian A; Delarue R; Vincenneau A; Amouroux I; Jeandel R; Khoury E; Martelli JM; Samson T; Tapia S; Flandrin G; Troussard X
Leuk Lymphoma; 2006 Sep; 47(9):1885-93. PubMed ID: 17065002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]